Capricor Therapeutics
A Manufacturing Associate I at Capricor Therapeutics plays a crucial role in the production of cell and exosome therapies for rare diseases. This position involves performing meticulous production tasks in a cleanroom environment to ensure compliance with quality and GMP standards. The associate is responsible for supporting clinical trials and contributing to the overall success of innovative therapeutic developments.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2005
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Capricor Therapeutics.
Capricor Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Duchenne trial drug from Capricor slows key task decline 83%
23 hours ago
Biotechnologist (CGT)
WayUp
Core Technician – Cell Therapy
Lonza
Core Technician – Cell Therapy
Lonza
Manufacturing Associate, Liso-cel CAR‑T, Manufacturing Operations
Bristol Myers Squibb
Manufacturing Associate, Liso-cel CAR-T, Manufacturing Operations
Bristol Myers Squibb
Core Technician I – Viral Vector
Lonza